Single and Multiple Doses of HA115 and Food Effect in Healthy Adult Volunteers
Withdrawn before enrolling · Phase 1 · Has a placebo group
Conditions studied: Asthma
In brief
This is a randomized, double-blind, placebo-controlled Phase 1 study of HA115 capsules administered orally to healthy adult volunteers.
Key facts
- Study ID
- NCT03567694
- Run by
- Conjupro Biotherapeutics, Inc.
- People needed
- 0
- Starts
- 2021-10-01
- Expected to finish
- 2022-10-12
- Last updated by the study team
- 2021-09-08
Who can join
Age: 18 and older, up to 55. Sex: any. Healthy volunteers: accepted.
Where it is running
- CNS Network — Long Beach, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.